The LMO2 oncogene, which is specifically associated with the ETP-ALL phenotype, can directly repress ZEB1 at the transcriptional level, and ZEB1 expression is negatively correlated with LMO2 expression in ETP-ALL cells. Here, LMO2 is linked to acute lymphoblastic leukemia.